GOLDMAN SACHS GROUP INC - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 2 filers reported holding MIRAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$40,000
-29.8%
51,2970.0%0.00%
Q2 2020$57,000
+147.8%
51,2970.0%0.00%
Q1 2020$23,000
-11.5%
51,297
-3.5%
0.00%
Q4 2019$26,000
-87.1%
53,171
-80.8%
0.00%
Q3 2019$202,000
-82.0%
276,251
-49.5%
0.00%
Q2 2019$1,121,000
+471.9%
546,889
+679.5%
0.00%
Q1 2019$196,000
+9.5%
70,156
+18.9%
0.00%
Q4 2018$179,000
-15.6%
58,993
+55.1%
0.00%
Q3 2018$212,000
-28.1%
38,031
-17.4%
0.00%
Q2 2018$295,000
-37.0%
46,039
-31.0%
0.00%
Q1 2018$468,000
-70.4%
66,699
-45.4%
0.00%
Q2 2017$1,580,000
+95.8%
122,183
+88.4%
0.00%
Q1 2017$807,00064,8450.00%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,142,580$2,451,0000.41%
Virtu Financial LLC 112,200$87,0000.02%
Seelaus Asset Management LLC 17,175$13,0000.01%
Aveo Capital Partners, LLC 16,732$13,0000.01%
Qube Research & Technologies Ltd 366,710$284,0000.00%
Banque Cantonale Vaudoise 50,000$39,0000.00%
GSA CAPITAL PARTNERS LLP 19,327$15,0000.00%
OneDigital Investment Advisors LLC 11,029$9,0000.00%
WELLS FARGO & COMPANY/MN 8,898$7,0000.00%
NORTHERN TRUST CORP 72,929$56,0000.00%
View complete list of MIRAGEN THERAPEUTICS INC shareholders